|Bid||0.0000 x 4000|
|Ask||0.0000 x 4000|
|Day's Range||4.2700 - 4.5100|
|52 Week Range||2.5200 - 12.5550|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 22, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.98|
The catalyst that sent the telehealth software company higher was bullish commentary courtesy of a Wall Street analyst. Piper Sandler analyst Sean Wieland raised his price target on American Well (also called Amwell) to $6, up from its previous level of $5. The analyst cited numerous client wins, including the recent signing of CVS Health (NYSE: CVS), which he sees as "marquee reference customers."
Among the hottest stocks last month was Amwell (NYSE: AMWL). It was shortly after the company reported earnings last month that Amwell's stock started to gain momentum. For the first three months of 2022, Amwell posted sales of $64.2 million which rose 12% year over year.
BOSTON, June 08, 2022--Amwell appoints Dr. Carrie Nelson to the role of Chief Medical Officer.